SXM CEO, Dr Sophia E. Shanko, invited to speak at the Stakeholder Meeting on “Innovative Antimicrobial Therapy Development” from the...
January 30, 2024
SXM opens three positions for R&D personnel excited to work and build the future of personalized antibiotic therapy era.
June 1, 2022
